Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 14.2 Million EUR | 1264.29% |
| 2022 | -1.28 Million EUR | 15.34% |
| 2021 | -1.51 Million EUR | 52.0% |
| 2020 | -3.15 Million EUR | -33.66% |
| 2019 | -2.36 Million EUR | -117.71% |
| 2018 | 13.33 Million EUR | 360.86% |
| 2017 | 2.89 Million EUR | -25.16% |
| 2016 | 3.86 Million EUR | 370.98% |
| 2015 | -1.42 Million EUR | 65.12% |
| 2014 | -4.09 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 17.61 Million EUR | 24.05% |
| 2024 Q2 | 17.61 Million EUR | 3.18% |
| 2023 Q3 | 14.66 Million EUR | 2710.31% |
| 2023 Q1 | 242.29 Thousand EUR | 118.89% |
| 2023 FY | 14.93 Million EUR | 1264.29% |
| 2023 Q2 | 521.9 Thousand EUR | 115.4% |
| 2023 Q4 | 14.2 Million EUR | -3.17% |
| 2022 Q2 | -15.14 Million EUR | 2.06% |
| 2022 FY | -1.28 Million EUR | 15.34% |
| 2022 Q3 | -1.58 Million EUR | 89.5% |
| 2022 Q4 | -1.28 Million EUR | 19.31% |
| 2022 Q1 | -15.46 Million EUR | -920.6% |
| 2021 Q2 | -14.33 Million EUR | 1.41% |
| 2021 FY | -1.51 Million EUR | 52.0% |
| 2021 Q4 | -1.51 Million EUR | 15.74% |
| 2021 Q3 | -1.79 Million EUR | 87.46% |
| 2021 Q1 | -14.54 Million EUR | -360.72% |
| 2020 FY | -3.15 Million EUR | -33.66% |
| 2020 Q4 | -3.15 Million EUR | 7.71% |
| 2020 Q3 | -3.42 Million EUR | 70.21% |
| 2020 Q2 | -11.48 Million EUR | 1.99% |
| 2020 Q1 | -11.71 Million EUR | -396.02% |
| 2019 FY | -2.36 Million EUR | -117.71% |
| 2019 Q2 | -10 Million EUR | 1.35% |
| 2019 Q1 | -10.14 Million EUR | -176.08% |
| 2019 Q4 | -2.36 Million EUR | 7.78% |
| 2019 Q3 | -2.56 Million EUR | 74.41% |
| 2018 Q3 | 10.38 Million EUR | 0.0% |
| 2018 FY | 13.33 Million EUR | 360.86% |
| 2018 Q1 | 1.68 Million EUR | -41.82% |
| 2018 Q4 | 13.33 Million EUR | 28.46% |
| 2017 Q4 | 2.89 Million EUR | 0.0% |
| 2017 FY | 2.89 Million EUR | -25.16% |
| 2016 FY | 3.86 Million EUR | 370.98% |
| 2015 FY | -1.42 Million EUR | 65.12% |
| 2014 FY | -4.09 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | 8.227% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | 1730.956% |
| Carmat SA | 49.63 Million EUR | 71.386% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | -23.203% |
| Euromedis Groupe | -8.82 Million EUR | 260.917% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 72.332% |
| Ikonisys S.A. | 3.19 Million EUR | -344.102% |
| Implanet S.A. | 5.9 Million EUR | -140.603% |
| Median Technologies SA | 3.5 Million EUR | -305.1% |
| SpineGuard SA | 215.79 Thousand EUR | -6481.56% |
| Theraclion SA | -5.86 Million EUR | 342.181% |
| Euroapi S.A. | 191 Million EUR | 92.564% |
| Guerbet SA | 332.59 Million EUR | 95.73% |
| Ion Beam Applications SA | -67.72 Million EUR | 120.972% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 99.756% |